XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 1 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,694 | +190.5% | 18,115 | +309.2% | 0.00% | – |
| Q2 2023 | $11,599 | +82750.0% | 4,427 | -50.6% | 0.00% | – |
| Q1 2023 | $14 | -44.0% | 8,961 | -52.5% | 0.00% | -100.0% |
| Q4 2022 | $25 | -100.0% | 18,867 | -74.1% | 0.00% | -50.0% |
| Q3 2022 | $114,000 | +132.7% | 72,857 | +128.1% | 0.00% | +100.0% |
| Q2 2022 | $49,000 | +16.7% | 31,944 | +93.8% | 0.00% | – |
| Q1 2022 | $42,000 | +50.0% | 16,479 | +75.3% | 0.00% | – |
| Q4 2021 | $28,000 | – | 9,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,641,920 | $14,781,830 | 42.66% |
| Stonepine Capital Management, LLC | 5,500,228 | $14,410,597 | 5.20% |
| MPM BioImpact LLC | 3,974,999 | $10,414,497 | 2.10% |
| Soleus Capital Management, L.P. | 2,054,105 | $5,381,755 | 0.60% |
| EAM Investors, LLC | 757,962 | $1,985,860 | 0.37% |
| DELTEC ASSET MANAGEMENT LLC | 406,190 | $1,064,218 | 0.23% |
| Alpine Global Management, LLC | 225,000 | $589,500 | 0.18% |
| Redmile Group, LLC | 1,046,587 | $2,742,058 | 0.10% |
| IHT Wealth Management, LLC | 281,442 | $737,379 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 127,091 | $332,978 | 0.04% |